Targeting menin: a promising therapeutic strategy for susceptible acute leukemia subtypes

A Novel Approach Towards a Vaccine for Relapsing Acute Myeloid Leukemia: Q&A with Dr. Karin Gaensler

A Box of Chemistry to Inhibit the MEN1 Tumor Suppressor Gene Promoting Leukemia - Ozyerli‐Goknar - 2021 - ChemMedChem - Wiley Online Library

Novel and Emerging Treatment Strategies for Acute Myeloid Leukemia in: Journal of the National Comprehensive Cancer Network Volume 18 Issue 7.5 (2020)

City of Hope presents pivotal clinical trial data at American Society of Hematology (ASH) conference on revumenib, a potential new targeted therapy for high-risk subtypes of acute leukemias

Current status and future perspectives in targeted therapy of NPM1-mutated AML

Targeting the undruggable: menin inhibitors ante portas

Leukemic stem cell signatures in Acute myeloid leukemia- targeting the Guardians with novel approaches

Children, Free Full-Text

IJMS, Free Full-Text

Frontiers Emerging Epigenetic Therapeutic Targets in Acute Myeloid Leukemia

Recent Progress of Small Molecule Menin–MLL Interaction Inhibitors as Therapeutic Agents for Acute Leukemia

Cellular Senescence: From Mechanisms to Current Biomarkers and Senotherapies

Relapsed pediatric acute myeloid leukaemia: state-of-the-art in 2023